Advances in Lung Transplantation for Patients Who Have Cystic Fibrosis

Clinics in Chest Medicine

Volumn 28, Issue 2, 2007, Pages 445-457

  Goldberg, Hilary J ^a,b   Deykin, Aaron ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID; TACROLIMUS;

AREA UNDER THE CURVE; BURKHOLDERIA; COMORBIDITY; CYSTIC FIBROSIS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION CONTROL; LUNG INFECTION; LUNG TRANSPLANTATION; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SOCIAL PSYCHOLOGY; SURGICAL TECHNIQUE;

CYSTIC FIBROSIS; HUMANS; LUNG TRANSPLANTATION; PATIENT SELECTION; REFERRAL AND CONSULTATION; RESPIRATORY FUNCTION TESTS;

EID: 34247535906     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2007.02.001     Document Type: Review

References (84)

1. Cystic fibrosis foundation, patient registry 2004 annual report. Available at: http://www.cff.org/ID=4573/TYPE=2676/2004PatientRegistryReport.pdf. Accessed November 22, 2006.
2. Yankaskas J.R., and Mallory Jr. G.B. Lung transplantation in cystic fibrosis: consensus conference statement. [review]. Chest 113 (1998) 217-226
3. Kerem E., Reisman J., Corey M., et al. Prediction of mortality in patients with cystic fibrosis. [see comment]. N Engl J Med 326 (1992) 1187-1191
4. Mayer-Hamblett N., Rosenfeld M., Emerson J., et al. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. [see comment]. Am J Respir Crit Care Med 166 (2002) 1550-1555
5. Augarten A., Akons H., Aviram M., et al. Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. [see comment]. Pediatr Transplant 5 (2001) 339-342
6. Robinson W., and Waltz D.A. FEV(1) as a guide to lung transplant referral in young patients with cystic fibrosis. Pediatr Pulmonol 30 (2000) 198-202
7. Milla C.E., and Warwick W.J. Risk of death in cystic fibrosis patients with severely compromised lung function. [see comment]. Chest 113 (1998) 1230-1234
8. Rosenbluth D.B., Wilson K., Ferkol T., et al. Lung function decline in cystic fibrosis patients and timing for lung transplantation referral. [see comment]. Chest 126 (2004) 412-419
9. Doershuk C.F., and Stern R.C. Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival. Chest 115 (1999) 782-787
10. Belkin R.A., Henig N.R., Singer L.G., et al. Risk factors for death of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 173 (2006) 659-666
11. Vizza C.D., Yusen R.D., Lynch J.P., et al. Outcome of patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 162 (2000) 819-825
12. Kadikar A., Maurer J., and Kesten S. The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant 16 (1997) 313-319
13. Fraser K.L., Tullis D.E., Sasson Z., et al. Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest 115 (1999) 1321-1328
14. Venuta F., Rendina E.A., Rocca G.D., et al. Pulmonary hemodynamics contribute to indicate priority for lung transplantation in patients with cystic fibrosis. J Thorac Cardiovasc Surg 119 (2000) 682-689
15. Stanchina M.L., Tantisira K.G., Aquino S.L., et al. Association of lung perfusion disparity and mortality in patients with cystic fibrosis awaiting lung transplantation. [see comment]. J Heart Lung Transplant 21 (2002) 217-225
16. Liou T.G., Adler F.R., and Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis. Am J Respir Crit Care Med 171 (2005) 1053-1059
17. Aurora P., Gassas A., Ehtisham S., et al. The effect of prelung transplant clinical status on post-transplant survival of children with cystic fibrosis. Eur Respir J 16 (2000) 1061-1064
18. Bartz R.R., Love R.B., Leverson G.E., et al. Pre-transplant mechanical ventilation and outcome in patients with cystic fibrosis. J Heart Lung Transplant 22 (2003) 433-438
19. Information for transplant professionals about the lung allocation scoring system. Available at: http://www.unos.org/SharedContentDocuments/lung_allocation.professionalv4.pdf. Accessed November 13, 2006.
20. Steinbach S., Sun L., Jiang R.Z., et al. Transmissibility of pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. [see comment]. N Engl J Med 331 (1994) 981-987
21. Heath D.G., Hohneker K., Carriker C., et al. Six-year molecular analysis of burkholderia cepacia complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J Clin Microbiol 40 (2002) 1188-1193
22. Ramirez J.C., Patterson G.A., Winton T.L., et al. Bilateral lung transplantation for cystic fibrosis. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg 103 (1992) 287-293
23. Snell G.I., de Hoyos A., Krajden M., et al. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. [see comment]. Chest 103 (1993) 466-471
24. Flume P.A., Egan T.M., Paradowski L.J., et al. Infectious complications of lung transplantation: impact of cystic fibrosis. Am J Respir Crit Care Med 149 (1994) 1601-1607
25. Egan J.J., McNeil K., Bookless B., et al. Post-transplantation survival of cystic fibrosis patients infected with pseudomonas cepacia. Lancet 344 (1994) 552-553
26. Coenye T., Vandamme P., Govan J.R., et al. Taxonomy and identification of the burkholderia cepacia complex. J Clin Microbiol 39 (2001) 3427-3436
27. LiPuma J.J., Spilker T., Gill L.H., et al. Disproportionate distribution of burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med 164 (2001) 92-96
28. Aris R.M., Routh J.C., LiPuma J.J., et al. Lung transplantation for cystic fibrosis patients with burkholderia cepacia complex: survival linked to genomovar type. Am J Respir Crit Care Med 164 (2001) 2102-2106
29. De Soyza A., McDowell A., Archer L., et al. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 358 (2001) 1780-1781
30. De Soyza A., Morris K., McDowell A., et al. Prevalence and clonality of burkholderia cepacia complex genomovars in UK patients with cystic fibrosis referred for lung transplantation. Thorax 59 (2004) 526-528
31. Manno G., Dalmastri C., Tabacchioni S., et al. Epidemiology and clinical course of burkholderia cepacia complex infections, particularly those caused by different burkholderia cenocepacia strains, among patients attending an Italian cystic fibrosis center. J Clin Microbiol 42 (2004) 1491-1497
32. De Boeck K., Malfroot A., Van Schil L., et al. Epidemiology of burkholderia cepacia complex colonisation in cystic fibrosis patients. Eur Respir J 23 (2004) 851-856
33. LiPuma J.J. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?. [review]. Transpl Infect Dis 3 (2001) 149-160
34. De Soyza A., and Corris P.A. Lung transplantation and the burkholderia cepacia complex. [review]. J Heart Lung Transplant 22 (2003) 954-958
35. Chaparro C., Maurer J., Gutierrez C., et al. Infection with burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med 163 (2001) 43-48
36. Kanj S.S., Tapson V., Davis R.D., et al. Infections in patients with cystic fibrosis following lung transplantation. [see comment]. Chest 112 (1997) 924-930
37. Khan S.U., Arroglia A.C., and Gordon S.M. Significance of airway colonization by burkholderia gladioli in lung transplant candidates. [comment]. Chest 114 (1998) 658
38. Walter S., Gudowius P., Bosshammer J., et al. Epidemiology of chronic pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis. Thorax 52 (1997) 318-321
39. Nunley D.R., Grgurich W., Iacono A.T., et al. Allograft colonization and infections with pseudomonas in cystic fibrosis lung transplant recipients. Chest 113 (1998) 1235-1243
40. Dobbin C., Maley M., Harkness J., et al. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre. J Hosp Infect 56 (2004) 277-282
41. Maurer J.R., Frost A.E., Estenne M., et al. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation 66 (1998) 951-956
42. Wise S.K., Kingdom T.T., McKean L., et al. Presence of fungus in sinus cultures of cystic fibrosis patients. Am J Rhinol 19 (2005) 47-51
43. Nunley D.R., Ohori P., Grgurich W.F., et al. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 114 (1998) 1321-1329
44. Helmi M., Love R.B., Welter D., et al. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest 123 (2003) 800-808
45. Saiman L., and Siegel J. Cystic Fibrosis Foundation Consensus Conference on Infection Control. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. [review]. Am J Infect Control 31 (2003) S1-S62
46. Holzmann D., Speich R., Kaufmann T., et al. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience. Transplantation 77 (2004) 134-136
47. Couetil J.P., Houssin D.P., Soubrane O., et al. Combined lung and liver transplantation in patients with cystic fibrosis: a 4 1/2-year experience. J Thorac Cardiovasc Surg 110 (1995) 1415-1422
48. Schaedel C., de Monestrol I., Hjelte L., et al. Predictors of deterioration of lung function in cystic fibrosis. Pediatr Pulmonol 33 (2002) 483-491
49. Rosenecker J., Hofler R., Steinkamp G., et al. Diabetes mellitus in patients with cystic fibrosis: the impact of diabetes mellitus on pulmonary function and clinical outcome. Eur J Med Res 6 (2001) 345-350
50. Moran A., Hardin D., Rodman D., et al. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. [see comment]. Diabetes Res Clin Pract 45 (1999) 61-73
51. Schwebel C., Pin I., Barnoud D., et al. Prevalence and consequences of nutritional depletion in lung transplant candidates. Eur Respir J 16 (2000) 1050-1055
52. Plochl W., Pezawas L., Artemiou O., et al. Nutritional status, ICU duration and ICU mortality in lung transplant recipients. Intensive Care Med 22 (1996) 1179-1185
53. Forli L., Bjortuft O., Vatn M., et al. A study of intensified dietary support in underweight candidates for lung transplantation. Ann Nutr Metab 45 (2001) 159-168
54. Madill J., Maurer J.R., and de Hoyos A. A comparison of preoperative and postoperative nutritional states of lung transplant recipients. Transplantation 56 (1993) 347-350
55. Thomas P. Lung versus heart-lung transplantation for cystic fibrosis: is the debate still open?. [comment]. Eur Respir J 25 (2005) 947-948
56. Ganesh J.S., Rogers C.A., Bonser R.S., et al. Outcome of heart-lung and bilateral sequential lung transplantation for cystic fibrosis: a UK national study. [see comment]. Eur Respir J 25 (2005) 964-969
57. Shennib H., Noirclerc M., Ernst P., et al. Double-lung transplantation for cystic fibrosis. The cystic fibrosis transplant study group. Ann Thorac Surg 54 (1992) 27-31
58. Vricella L.A., Karamichalis J.M., Ahmad S., et al. Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: the Stanford experience. Ann Thorac Surg 74 (2002) 13-17
59. Shennib H., Massard G., Gauthier R., et al. Single lung transplantation for cystic fibrosis: is it an option? Cystic Fibrosis Transplant Study Group. J Heart Lung Transplant 12 (1993) 288-293
60. Bremner R.M., Woo M.S., Arroyo H., et al. The effect of pleural adhesions on pediatric cystic fibrosis patients undergoing lung transplantation. Am Surg 67 (2001) 1136-1139
61. Barr M.L., Baker C.J., Schenkel F.A., et al. Living donor lung transplantation: selection, technique, and outcome. [review]. Transplant Proc 33 (2001) 3527-3532
62. Date H., Aoe M., Nagahiro I., et al. Living-donor lobar lung transplantation for various lung diseases. J Thorac Cardiovasc Surg 126 (2003) 476-481
63. Egan T.M., Detterbeck F.C., Mill M.R., et al. Lung transplantation for cystic fibrosis: effective and durable therapy in a high-risk group. Ann Thorac Surg 66 (1998) 337-346
64. Aurora P., Whitehead B., Wade A., et al. Lung transplantation and life extension in children with cystic fibrosis. Lancet 354 (1999) 1591-1593
65. Venuta F., Rendina E.A., De Giacomo T., et al. Improved results with lung transplantation for cystic fibrosis. Transplant Proc 33 (2001) 1632-1633
66. Egan T.M., Detterbeck F.C., Mill M.R., et al. Long term results of lung transplantation for cystic fibrosis. Eur J Cardiothorac Surg 22 (2002) 602-609
67. de Perrot M., Chaparro C., McRae K., et al. Twenty-year experience of lung transplantation at a single center: influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 127 (2004) 1493-1501
68. Lama R., Alvarez A., Santos F., et al. Long-term results of lung transplantation for cystic fibrosis. Transplant Proc 33 (2001) 1624-1625
69. Hosenpud J.D., Bennett L.E., Keck B.M., et al. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. [see comment]. Lancet 351 (1998) 24-27
70. Burker E.J., Carels R.A., Thompson L.F., et al. Quality of life in patients awaiting lung transplant: cystic fibrosis versus other end-stage lung diseases. Pediatr Pulmonol 30 (2000) 453-460
71. Vermeulen K.M., van der Bij W., Erasmus M.E., et al. Improved quality of life after lung transplantation in individuals with cystic fibrosis. Pediatr Pulmonol 37 (2004) 419-426
72. Kurland G., and Orenstein D.M. Lung transplantation and cystic fibrosis: the psychosocial toll. Pediatrics 107 (2001) 1419-1420
73. Durst C.L., Horn M.V., MacLaughlin E.F., et al. Psychosocial responses of adolescent cystic fibrosis patients to lung transplantation. Pediatr Transplant 5 (2001) 27-31
74. Groen H., van der Bij W., Koeter G.H., et al. Cost-effectiveness of lung transplantation in relation to type of end-stage pulmonary disease. Am J Transplant 4 (2004) 1155-1162
75. Gilljam M., Chaparro C., Tullis E., et al. GI complications after lung transplantation in patients with cystic fibrosis. [see comment]. Chest 123 (2003) 37-41
76. Minkes R.K., Langer J.C., Skinner M.A., et al. Intestinal obstruction after lung transplantation in children with cystic fibrosis. J Pediatr Surg 34 (1999) 1489-1493
77. Knoop C., Vervier I., Thiry P., et al. Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditions. Transplantation 76 (2003) 683-688
78. Tsang V.T., Johnston A., Heritier F., et al. Cyclosporin pharmacokinetics in heart-lung transplant recipients with cystic fibrosis: effects of pancreatic enzymes and ranitidine. Eur J Clin Pharmacol 46 (1994) 261-265
79. Reynaud-Gaubert M., Viard L., Girault D., et al. Improved absorption and bioavailability of cyclosporine A from a microemulsion formulation in lung transplant recipients affected with cystic fibrosis. Transplant Proc 29 (1997) 2450-2453
80. Mikhail G., Eadon H., Leaver N., et al. An investigation of the pharmacokinetics, toxicity, and clinical efficacy of neoral cyclosporin in cystic fibrosis patients. Transplant Proc 29 (1997) 599-601
81. Mikhail G., Eadon H., Leaver N., et al. Comparison of neoral and sandimmun cyclosporines for de novo lung transplantation in cystic fibrosis patients. Transplant Proc 30 (1998) 1510-1511
82. Walker S., Habib S., Rose M., et al. Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis. Transplant Proc 30 (1998) 1519-1520
83. Knoop C., Thiry P., Saint-Marcoux F., et al. Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions. Am J Transplant 5 (2005) 1477-1482
84. Gerbase M.W., Fathi M., Spiliopoulos A., et al. Pharmacokinetics of mycophenolic acid associated with calcineurin inhibitors: long-term monitoring in stable lung recipients with and without cystic fibrosis. J Heart Lung Transplant 22 (2003) 587-590